CSL share price higher on key Seqirus appointment

The CSL Limited (ASX:CSL) share price has pushed higher this morning after naming the new leader of its growing Seqirus business…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Limited (ASX: CSL) share price has edged higher this morning following the announcement of a key appointment.

At the time of writing the biotherapeutics giant's shares are up 0.25% to $223.13.

What did CSL announce?

This morning CSL Limited announced that it has appointed Ms Anjana Narain as the executive vice president and general manager of its Seqirus business.

CSL's Seqirus business is one of the world's largest influenza vaccines providers.

According to the release, Ms Narain is a seasoned leader in vaccines and biopharmaceuticals and is due to start with the company on August 1, replacing the retiring Gordon Naylor.

CSL's CEO and managing director, Paul Perreault, spoke very highly of Ms Narain. He said: "In leading Seqirus, Anjana brings diverse, broad-based experiences as a well established global industry leader."

Adding: "Anjana has focused on protecting public health throughout her career which will be important in continuing to advance Seqirus' differentiated technologies and further grow its market reach. I look forward to working with Anjana and the rest of our management team in executing our strategy and continuing to sustainably grow our global business."

Ms Narain certainly appears to be a good fit for the fast-growing influenza vaccines provider.

The release explains that she has a track record of strategic vision and strong leadership that has delivered industry-leading performance and sustainable growth.

The new leader of the Seqirus business has 27 years of experience with major pharmaceutical companies such as GSK, Merck, and Bayer.

Importantly, for nine years, Ms Narain led major businesses at GSK, including global influenza commercialisation, US respiratory biologics, and general management of vaccines, primary care and HIV.

She was also a member of the global vaccines commercial leadership team and the intercontinental leadership team.

Ms Narain said: "As a global leader in influenza prevention, Seqirus is well positioned to deliver sustainable growth. I am excited to lead an organisation that is on the front line in protecting public health around the world."

Today's small gain means that CSL's shares are up over 20% since the start of the year. This makes its shares one of the best performers in the healthcare sector along with Cochlear Limited (ASX: COH) shares with their 27% gain and Ramsay Health Care Limited (ASX: RHC) shares with their 25.5% gain.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Fortescue, Lynas, PEXA, and Regis Healthcare shares are charging higher

These shares are having a strong session on Thursday. But why?

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Share Gainers

Why Capricorn Metals, Insignia, Perseus Mining, and Qoria shares are storming higher

These shares are having a strong session on Tuesday. But why?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Amaero, AMP, Block, and South32 shares are racing higher today

These shares are starting the week on a positive note. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another momentous session for ASX shares this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

A businessman stacks building blocks.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX shares hit a new record high today.

Read more »

A man sees some good news on his phone and gives a little cheer.
Share Gainers

Why Auckland Airport, Australian Ethical, Breville, and Clarity shares are charging higher

These shares are having a better day than most on Thursday. But why?

Read more »